Back
Recursion Pharmaceuticals Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
60
RXRX
Recursion Pharmaceuticals
Last Price:
7.22
Seasonality Move:
10.07%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- The current trend is moderately bullish and RXRX is experiencing selling pressure, which indicates risk of future bearish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.15 | Buy |
| 20-day SMA: | 6.83 | Buy |
| 50-day SMA: | 6.63 | Buy |
| 200-day SMA: | 8.44 | Sell |
| 8-day EMA: | 7.2 | Buy |
| 20-day EMA: | 6.92 | Buy |
| 50-day EMA: | 6.86 | Buy |
| 200-day EMA: | 7.79 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 57.54 | Buy |
| Chaikin Money Flow: | -6515679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.36 - 7.16) | Buy |
| Bollinger Bands (100): | (6.32 - 7.82) | Buy |
Recursion Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 7.31 while RXRX 8-day simple moving average is 7.15, which is a Buy signal.
- The stock price of RXRX is 7.31 while Recursion Pharmaceuticals 20-day SMA is 6.83, which makes it a Buy.
- Recursion Pharmaceuticals 50-day simple moving average is 6.63 while RXRX share price is 7.31, making it a Buy technically.
- RXRX stock price is 7.31 and Recursion Pharmaceuticals 200-day simple moving average is 8.44, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Buy
60
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Buy
The current Recursion Pharmaceuticals [RXRX] share price is $7.31. The Score for RXRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.1B
Price in USD:
7.31
Share Volume:
6.52M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
5.89
Buy
60
Recursion Pharmaceuticals (RXRX)
is a Buy
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 7.31 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is not overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 7.31 while RXRX 8-day exponential moving average is 7.20, which is a Buy signal.
- The stock price of RXRX is 7.31 while Recursion Pharmaceuticals 20-day EMA is 6.92, which makes it a Buy.
- Recursion Pharmaceuticals 50-day exponential moving average is 6.86 while RXRX share price is 7.31, making it a Buy technically.
- RXRX stock price is 7.31 and Recursion Pharmaceuticals 200-day simple moving average is 7.79, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Recursion Pharmaceuticals is a Buy
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 57.54, which suggest Recursion Pharmaceuticals is overbought
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.36 - 7.16), which suggest Recursion Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.32 - 7.82), which suggest Recursion Pharmaceuticals is a Buy
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.